Shasun Pharma And Strides Arcolab To Merge Next Year
Advertisement
Advertisement
Advertisement
Shasun shareholders will own 26% of the combined entity, and will set up a vertically integrated
Strides Arcolab, which also made a filing to the Bombay Stock Exchange, said a scheme of amalgamation between the two companies has got the nod of the board of directors of both companies.
“The combination creates a vertically-integrated pharma company of scale with strong presence in front-ended regulated markets finished dosages, emerging markets branded generics, institutional business, active pharmaceutical ingredients and contract research and manufacturing services,” the press release of Strides said. The merger is likely to materialise by June next year.
Advertisement
- Tesla tells some laid-off employees their separation agreements are canceled and new ones are on the way
- Taylor Swift's 'The Tortured Poets Department' is the messiest, horniest, and funniest album she's ever made
- One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
- The Future of Gaming Technology
- Stock markets stage strong rebound after 4 days of slump; Sensex rallies 599 pts
- Sustainable Transportation Alternatives
- 10 Foods you should avoid eating when in stress
- 8 Lesser-known places to visit near Nainital